Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
25/07/2025 16:10
July 25 (Reuters) - PuraPharm Corp Ltd 1498.HK: TO ISSUE CONSIDERATION SHARES AS LICENCE FEE OF HK$40.2 MILLION TO ISSUE 46.5 MILLION SUBSCRIPTION SHARES FOR GROSS PROCEEDS OF HK$20 MILLION Further company coverage: 1498.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln